| GWAS |
- Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU) ( 24025145
)
- Amyotrophic lateral sclerosis (sporadic) ( 24529757
)
- Arterial stiffness (brachial-femoral pulse wave velocity) ( 32790701
)
- Asthma (childhood onset) ( 27611488
)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885
)
- Brain morphology (MOSTest) ( 32665545
)
- Lead levels ( 26025379
)
- Lung function (FEV1) ( 30061609
)
- Lung function (FVC) ( 30061609
)
- Monobrow ( 27182965
)
- Neuritic plaque ( 31497858
)
- Nose size ( 27182965
)
- Parkinson's disease ( 26227905
)
- Superior frontal gyrus grey matter volume ( 25335168
)
- Systolic blood pressure ( 26969751
)
- Thyroid volume in Hashimoto’s thyroiditis ( 32019955
)
|
- Autoimmune thyroid disease ( 32581359
)
- Daytime nap ( 33568662
)
- Gemcitabine-induced early high-grade neutropenia in pancreatic cancer ( 30889042
)
- Mean corpuscular hemoglobin ( 32888494
)
- Nickel levels ( 26025379
)
- Obesity-related traits ( 23251661
)
- Periodontitis (Mean PAL) ( 24024966
)
- QT interval (sulfonylurea treatment interaction) ( 27958378
)
- Rhegmatogenous retinal detachment ( 23585552
)
- Systemic juvenile idiopathic arthritis ( 27927641
)
- Toenail selenium levels ( 25343990
)
|
